Mediterranean diet linked to health outcomes
Mediterranean diet linked to better brain health, reduced cancer risk, lower blood pressure, and gut health benefits.

Research indicates that adherence to a Mediterranean-type diet correlates with several positive health outcomes. Studies in 2025 have associated this dietary pattern with improved brain health, reduced cancer risk, and lower blood pressure.
Further analysis suggests a potential link between the Mediterranean diet and gut health, which may influence broader physiological functions. Modified versions, such as the Green Mediterranean diet and the MIND diet, have been developed to address specific health concerns.
The Green Mediterranean diet, which excludes meat, has been associated with reduced visceral fat and potential benefits for brain aging and blood sugar regulation. The MIND diet specifically targets cognitive decline by combining elements of the Mediterranean and DASH diets.
These findings suggest that dietary interventions based on Mediterranean principles may offer strategies for managing age-related health issues and promoting overall well-being.
More stories
- Cochrane seeks Nov. 30 bids for adult pneumococcal vaccine review
- Athlete eye-balance screens may move beyond concussion rehab
- Conflict-zone athletes face sleep stress standard plans miss
- Tai Chi may ease pain in musculoskeletal disorders
- Peptide access push may obscure patient harm reports
- ACL graft choice shows no revision link in Swedish football study
- A New Epidemic? Why Experts Say the Hondius Outbreak Is Alarming — but Not That
- Three Dead After Suspected Hantavirus Outbreak on Atlantic Cruise Ship
Latest news
- Bonfiglioli Transmissions IPO to cut promoter stake to 77%
- Faraday gives BHP 32% stake in San Manuel deal
- Istanbul flooding prompts school closures and road bans
- Trump halts execution livestream plan after backlash grows
- Albania protests intensify as Rama rejects calls to resign
- Zampolli loses envoy post after reported diplomatic feud
- Anthropic IPO plans take focus as smaller US deals stall
- US official denies Trump Starshield restriction directive

